Bio-Rad buys Provalis' medical diagnostics business for $3 million

By Angela McDaniels

Seattle, Sept. 7 - Bio-Rad Laboratories, Inc. has completed the purchase of the medical diagnostics business of Provalis plc for roughly $3 million in cash, according to a Bio-Rad news release.

The acquired business is based in Deeside, England, and develops, manufactures and sells point-of-care diagnostic products for ongoing management of diabetes and osteoporosis.

"Point-of-care testing continues to be of growing importance in the diagnostics area. While this is a relatively small acquisition, it expands our market breadth in the very critical area of diabetes monitoring," Bio-Rad president and chief executive officer Norman Schwartz said in the release.

Bio-Rad Laboratories, based in Hercules, Calif., manufactures and distributes life science research products and clinical diagnostics.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.